Mankyu Park

Directeur/Membre du Conseil chez

Coagulant Therapeutics, Inc.

Consumer Services

Finance

Health Technology

Profil

Mankyu is a Principal at DTCP in the Growth Equity team and covers Korea-based investments.
Mankyu came to DTCP from L&S Venture Capital, a leading Korean VC specializing in IT, semiconductors, and display investments.
Prior to that he held positions in the investment banking division of KB Securities and at Partners Group.
Mankyu made investments in IT, AI, Bio/Life science, mobile platforms, and other tech sectors.
Mankyu also led a couple of mid-to-large size deals like Youngin Engineering and Coagulant Therapeutics where top-tier Korean local VCs participated.
Mankyu holds a bachelor’s degree in business administration with concentration on finance from Goizueta Business School, Emory University.

Postes actifs de Mankyu Park

Sociétés	Poste	Début
Coagulant Therapeutics, Inc. Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma	Directeur/Membre du Conseil	-

Tous les postes actifs de Mankyu Park

Anciens postes connus de Mankyu Park

Sociétés	Poste	Fin
DTCP Management GmbH DTCP Management GmbH Investment ManagersFinance Functions as an alternative investment manager	Corporate Officer/Principal	-

Voir l'expérience en détail de Mankyu Park

Formation de Mankyu Park

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mankyu Park

Sociétés liées

Entreprise privées	3
Goizueta Business School-Emory Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
DTCP Management GmbH DTCP Management GmbH Investment ManagersFinance Functions as an alternative investment manager	Finance
Coagulant Therapeutics, Inc. Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat acute bleeding and unmet medical need that postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma	Health Technology